RA Capital Healthcare Fund LP's Form 4 filing
iTeos Therapeutics, Inc. (ITOS) · filed May 14, 2024
- Accession no.
- 0001415889-24-013171
- Filed
- May 14, 2024, 9:06 PM ET
- Trade date
- May 10-12, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | Other: Former 10% Owner |
| Ra Capital Management, L.P.CIK 0001346824 | Other: Former 10% Owner |
| Kolchinsky PeterCIK 0001384859 | Other: Former 10% Owner |
| Shah Rajeev M.CIK 0001619841 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 12, 2024 | Common Stock | JOtherDisposed | −900,000 | –F1 | – | 2,545,510 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | Common Stock | PPurchaseAcquired | +5,714,285 | $17.50 | +$99,994,273.22 | 5,714,285 | Indirect | |
| May 12, 2024 | Common Stock | JOtherAcquired | +900,000 | –F1 | – | 6,614,285 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On May 12, 2024, RA Capital Healthcare Fund, L.P. (the "Fund") entered into an exchange agreement with the Issuer, pursuant to which the Fund agreed to exchange 900,000 shares of the Issuer's Common Stock for a pre-funded warrant to purchase up to 900,000 shares of Common Stock.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.